Klaus K. Orlinger

662 total citations
29 papers, 497 citations indexed

About

Klaus K. Orlinger is a scholar working on Infectious Diseases, Genetics and Epidemiology. According to data from OpenAlex, Klaus K. Orlinger has authored 29 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 15 papers in Genetics and 9 papers in Epidemiology. Recurrent topics in Klaus K. Orlinger's work include Viral Infections and Outbreaks Research (17 papers), Virus-based gene therapy research (15 papers) and Viral Infections and Vectors (9 papers). Klaus K. Orlinger is often cited by papers focused on Viral Infections and Outbreaks Research (17 papers), Virus-based gene therapy research (15 papers) and Viral Infections and Vectors (9 papers). Klaus K. Orlinger collaborates with scholars based in Switzerland, Austria and United States. Klaus K. Orlinger's co-authors include Perry Barrett, Thomas R. Kreil, Regina M. Kofler, Falko G. Falkner, Georg W. Holzer, Christian W. Mandl, Richard Fritz, Hartmut J. Ehrlich, Michael G. Schwendinger and Daniel D. Pinschewer and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Klaus K. Orlinger

28 papers receiving 476 citations

Peers

Countries citing papers authored by Klaus K. Orlinger

Since Specialization

Citations

This map shows the geographic impact of Klaus K. Orlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus K. Orlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus K. Orlinger more than expected).

Fields of papers citing papers by Klaus K. Orlinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus K. Orlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus K. Orlinger. The network helps show where Klaus K. Orlinger may publish in the future.

Co-authorship network of co-authors of Klaus K. Orlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus K. Orlinger. A scholar is included among the top collaborators of Klaus K. Orlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus K. Orlinger. Klaus K. Orlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates 2024 ·Vaccines ·Bhawna Sharma, Elena Bekerman, Hoa Truong, Johnny W. Lee, (unknown), Archana V. Boopathy, (unknown), (unknown), (unknown), (unknown), (unknown), Henning Lauterbach, Klaus K. Orlinger, Silpa Suthram, Mark G. Lewis, Wade Blair, Tariro Makadzange, Romas Geleziunas, Jeffrey P. Murry, Sarah Schmidt	1
2	Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Catarina Pinto, (unknown), Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, (unknown), Sarah Schmidt, (unknown), (unknown), (unknown), Ethan L. Stewart, Jakub Jeż, Pedro Berraondo, Klaus K. Orlinger, Henning Lauterbach	4
3	Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Myriam Fernández-Sendin, Maite Álvarez, (unknown), (unknown), Fernando Aranda, (unknown), Marisol Quintero, Ignacio Melero, Klaus K. Orlinger, Henning Lauterbach, Pedro Berraondo	2
4	Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers 2023 ·The Journal of Infectious Diseases ·Sarah Schmidt, (unknown), Stéphane Daffis, (unknown), (unknown), (unknown), (unknown), (unknown), Adrian Tomkinson, Mohammad Nizam Uddin, (unknown), Michael D. Robek, Jason K. Perry, Henning Lauterbach, Klaus K. Orlinger, Simon P. Fletcher, Scott Balsitis	4
5	Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys 2023 ·npj Vaccines ·Archana V. Boopathy, Bhawna Sharma, (unknown), (unknown), (unknown), Silpa Suthram, Hoa Truong, Johnny W. Lee, Jiani Li, Ross Martin, Wade Blair, Romas Geleziunas, Klaus K. Orlinger, (unknown), Henning Lauterbach, Tariro Makadzange, (unknown), Sarah Schmidt	3
6	Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment 2021 ·Nature Communications ·Sandra S. Ring, Jovana Cupovic, Lucas Onder, Mechthild Lütge, Christian Perez‐Shibayama, Cristina Gil‐Cruz, Elke Scandella, Angelina De Martin, Urs Mörbe, (unknown), (unknown), (unknown), Andrej Bešše, Weldy V. Bonilla, (unknown), Sarah Schmidt, Klaus K. Orlinger, Philippe Krebs, Burkhard Ludewig, Lukas Flatz	21
7	Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack 2021 ·Cell Reports Medicine ·Weldy V. Bonilla, Nicole Kirchhammer, Anna‐Friederike Marx, Sandra M. Kallert, Magdalena A. Krzyzaniak, Min Lu, Stéphanie Darbre, Sarah Schmidt, (unknown), Ursula Berka, Ilena Vincenti, (unknown), Romy Kerber, Sabine Hoepner, Stephan Günther, Carsten Magnus, Doron Merkler, Klaus K. Orlinger, Alfred Zippelius, Daniel D. Pinschewer	22
8	Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform 2021 ·Frontiers in Oncology ·Henning Lauterbach, Sarah Schmidt, (unknown), Xiaoping Qing, (unknown), (unknown), Katia Schlienger, Ursula Berka, (unknown), (unknown), (unknown), (unknown), Daniel D. Pinschewer, Igor Matushansky, Klaus K. Orlinger	15
9	Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer 2020 ·OncoImmunology ·Sarah Schmidt, Weldy V. Bonilla, Andrea Reiter, (unknown), (unknown), (unknown), Ursula Berka, Ahmed El‐Gazzar, (unknown), (unknown), (unknown), Mohamed Habbeddine, (unknown), Xiaoping Qing, Henning Lauterbach, Igor Matushansky, Daniel D. Pinschewer, Klaus K. Orlinger	13
10	Abstract B131: Live-attenuated LCMV-based vector for active immunotherapy of HPV16+ cancer 2019 ·Cancer Immunology Research ·Sarah Schmidt, Ahmed El‐Gazzar, Weldy V. Bonilla, (unknown), Andrea Reiter, (unknown), (unknown), (unknown), Ursula Berka, (unknown), (unknown), Igor Matushansky, Doron Merkler, Daniel D. Pinschewer, Klaus K. Orlinger	1
11	Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations 2017 ·Molecular Therapy ·(unknown), Dmitrij Ostroumov, Norman Woller, Michael P. Manns, Daniel D. Pinschewer, Klaus K. Orlinger, Ursula Berka, Florian Kühnel, Thomas Wirth	10
12	Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector 2016 ·Clinical and Vaccine Immunology ·Mark R. Schleiss, Ursula Berka, (unknown), (unknown), (unknown), Bastien Mangeat, Elizabeth C. Swanson, (unknown), Nelmary Hernandez-Alvarado, Claudia Fernández-Alarcón, (unknown), Daniel D. Pinschewer, Anders Lilja, Michael G. Schwendinger, Farshad Guirakhoo, Thomas P. Monath, Klaus K. Orlinger	32
13	Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection 2016 ·Vaccine ·Rhonda D. Cardin, Fernando Bravo, (unknown), Klaus K. Orlinger, (unknown), (unknown), (unknown), Farshad Guirakhoo, Thomas P. Monath, David I. Bernstein	27
14	Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes 2011 ·Vaccine ·Richard Fritz, Klaus K. Orlinger, (unknown), (unknown), Andreas Traweger, Laura Perez-Burgos, Perry Barrett, Thomas R. Kreil	37
15	A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans 2011 ·The Journal of Infectious Diseases ·Klaus K. Orlinger, (unknown), Richard Fritz, Georg W. Holzer, Falko G. Falkner, Bernd Unger, Alexandra Loew-Baselli, (unknown), Hartmut J. Ehrlich, Perry Barrett, Thomas R. Kreil	83
16	Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity 2011 ·PLoS ONE ·(unknown), Michael G. Schwendinger, Georg W. Holzer, Klaus K. Orlinger, (unknown), Helga Savidis-Dacho, (unknown), Brian A. Crowe, Thomas R. Kreil, Hartmut J. Ehrlich, Perry Barrett, Falko G. Falkner	45
17	An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system 2010 ·Vaccine ·Klaus K. Orlinger, Georg W. Holzer, Julia Schwaiger, (unknown), (unknown), Otfried Kistner, Perry Barrett, Falko G. Falkner	21
18	Analysis of the effects of alterations in the tick-borne encephalitis virus 3′-noncoding region on translation and RNA replication using reporter replicons 2008 ·Virology ·(unknown), Harald Rouha, Klaus K. Orlinger, Lisa Miorin, Alessandro Marcello, Regina M. Kofler, Christian W. Mandl	38
19	Selection and Analysis of Mutations in an Encephalomyocarditis Virus Internal Ribosome Entry Site That Improve the Efficiency of a Bicistronic Flavivirus Construct 2007 ·Journal of Virology ·Klaus K. Orlinger, Regina M. Kofler, Franz X. Heinz, (unknown), Christian W. Mandl	9
20	Construction and Mutagenesis of an Artificial Bicistronic Tick-Borne Encephalitis Virus Genome Reveals an Essential Function of the Second Transmembrane Region of Protein E in Flavivirus Assembly 2006 ·Journal of Virology ·Klaus K. Orlinger, (unknown), Regina M. Kofler, Christian W. Mandl	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact